Project Grant 1926845

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) Project Grant award of $275,000 to Astria Biosciences, Inc. seeks to develop the first simple, whole blood-based diagnostic test to detect the presence and monitor the progression of cerebral aneurysms (CAs). The project aims to generate a robust dataset of CA patient blood samples, with a focus on increasing representation from underserved...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $739,772 to Cian, Inc. to develop a biomarker kit for improved diagnosis and prognosis of traumatic brain injury (TBI). The key products and services to be delivered through this 24-month award are: 1) the development of monoclonal antibodies targeting two proteins...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $307,538 to Sage Cerebrovascular Diagnostics, Inc. to develop and validate a novel, minimally invasive diagnostic assay to discriminate Alzheimer's disease from vascular dementia. The award aims to: 1) establish the assay's performance characteristics in a clinical laboratory environment, 2) identify the optimal at-home sample collection methodology, and 3) determine the assay's sensitivity...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $704,313 to Trustees of Boston University to advance the development of a prognostic and monitoring biomarker for neutrophil-driven secondary brain injury in patients with spontaneous intracerebral hemorrhage (SICH). The key objectives are to: 1) define and validate a standardized...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding the development of an innovative portable device to rapidly detect and monitor traumatic brain injury (TBI) biomarkers. The $332,122 award to Hemex Health Inc. aims to create a point-of-care diagnostic platform that can quickly analyze whole blood samples to identify elevated...

This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Aneurisk, Inc. to develop and validate machine learning models for risk classification, growth projection, and wall stress prediction for abdominal aortic aneurysms (AAA). The project aims to create an artificial intelligence-based clinical decision support tool that enables clinicians to improve the treatment of patients with...

Qas.ai Inc. was awarded a $255,577 Small Business Technology Transfer (STTR) Phase I Project Grant by the National Science Foundation on July 15, 2021 to develop an AI-enhanced angiographic system to guide endovascular treatment of intracranial aneurysms. The STTR Phase I Project Grant program, administered under the National Science Foundation's Technology, Innovation, and Partnerships Directorate (TIP), provides funding for the exploration of the technical feasibility or scientific merit of an...

This $498,995 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) platform for the real-time, non-invasive measurement of cerebral blood flow. The research aims to address the limitations of current stroke diagnosis and monitoring techniques...

This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Beken Bio, Inc. aims to develop a highly sensitive, minimally invasive laboratory test to detect early-stage ovarian cancer by assaying relevant biomarkers on circulating extracellular vesicles in patient plasma. The project will utilize a novel technology to identify key proteins in extracellular vesicles from various ovarian cancer subtypes and employ a machine...

This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA Program "Discovery and Applied Research for Technological Innovations to Improve Human Health", is funding the development of a passive, shunt-mountable intracranial pressure (ICP) sensor that can be wirelessly interrogated using ultrasound. The total award amount is $131,085, with a project period from June 9, 2025 to May 31, 2027. The key objectives are to: 1)...